Journal article

CD151 and cell motility in prostate cancer

Sujitra Detchokul, Michael W Parker, Elizabeth D Williams, Olivia M Herdiman, Melissa Davis, Kelvin Kee, Damien M Bolton, Albert G Frauman

CANCER RESEARCH | AMER ASSOC CANCER RESEARCH | Published : 2012

Abstract

Abstract Prostate cancer (PCa) is one of the leading causes of cancer death in men. CD151 is a member of the tetraspanin family and is associated with regulation of migration of normal and tumour cells via cell surface microdomain formation. Previous studies from our laboratory revealed that expression of CD151 differs across histological grades of PCa and high levels of expression are linked to shorter survival, independent of Gleason score1. In vitro motility assays of human PCa cell lines suggest CD151 is a motility promoter2. We have sought to develop a number of CD151 inhibitors and examine their ability to modulate prostate cancer motility and metastasis. The human PCa c..

View full abstract